It publishes review articles, original articles, brief communications, correspondences, case reports, editorials, and special articles covering an extensive range of clinical descriptions on infectious diseases, public health issues, microbiology including emerging resistance, parasitology and immunity to microbes, current and novel treatments, antimicrobial stewardship, and the promotion of optimal practices or guidelines for diagnoses and treatments representative of Korea and other countries or academic societies.Infect Chemother also covers the emerging and niche fields of infectious diseases such as multidrug resistant bacterial diseases, new drugs and vaccines, pandemic or emerging viral diseases, infectious diseases that are prevalent only in East Asia including Korea, and infectious diseases that have been forgotten.As the world continues to shrink as a result of globalization, it is necessary that appropriate communication is maintained among countries for timely sharing of information on infectious diseases.This is an important topic because such diseases tend to have unique biologic features according to the regions in which they develop, and these diseases can easily become nidus that may spread globally at any time.Based on these factors, the aim of this publication is to facilitate communication among societies and countries, enabling the worldwide sharing of information on infectious diseases.The scope of this journal is to link basic and clinical research in the field of infectious diseases, in reference to relevant evidence.The journal continuously attempts to publish current global and regional topics concerning infectious diseases and their diagnoses and managements to create awareness of related issues and link various developing and developed countries.
A Thu, study studied this question.